ArticleTropical animal health and production2026
Evaluating poultry by-product meal, tomato pomace, and azolla with or without Natuzyme supplementation as sustainable alternatives to fish meal for Nile tilapia (Oreochromis niloticus).
Article in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several studies have predicted that developing countries will be unable to afford fish meal as a primary aquafeed protein source in the future. This experiment evaluated the effect of replacing fish meal (FM) with poultry by-product meal (PBM), tomato pomace, and azolla growth, physiological, and histological parameters, besides their economic impact on Nile Tilapia (Oreochromis niloticus). A total of 270 fish were randomly allocated to 6 groups (initial weight average was 12.08 g). The groups are as follows: a fish meal-based diet (Tc), a poultry by-products meal-based diet (Tp), a T. pomace-based diet (Tt), Tt supplemented with Natuzyme (Tte), an azolla-based diet (Ta), and Ta supplemented with Natuzyme (Tae). Regarding the growth performance Tp, Ta, and Tae were secondary to Tc and followed by Tt and Tte. The hematological and biochemical indicators didn’t differ among groups. The Azolla-based groups had the lowest hepatosomatic index and the highest carcass fat and protein. Glutathione and interleukin-10 were higher in T.pomace and azolla enzyme-based diets. Malondialdehyde and tumor necrosis factor-alpha were lower in Tt, Tte and Tae. Standard histological findings were observed in the spleen, kidney, and liver among groups. Tp, Ta, and Tae significantly showed the highest absorption surface area (ASA) compared to Tt and Tte. The photomicrographs demonstrated negative expression of nuclear factor kappa B (NF-κB) in all treatments. Tp outperformed Tc 45% economically, and azolla matched PBM. It could be concluded that Azolla serves as a plant-based alternative. PBM represents a sustainable, cost-effective replacement for FM, reducing reliance on conventional marine-alternative proteins.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.